BAM Stock Analysis: Brookfield Asset Management | NYSE
Asset Management | NYSE, USA | Market Cap: 75.135m USD | 12M Return: -6.5% | CA1130041058 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 124M
EPS Trend: 98.3%
Qual. Beats: 0
Rev. Trend: 85.0%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 5.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Brookfield Asset Management Ulc is a private equity and alternative asset management firm that focuses on acquisitions and growth capital investments across real asset categories, including real estate, infrastructure, renewable power, private equity, and credit. The firm serves a broad institutional client base, such as pension plans, sovereign wealth funds, endowments, foundations, financial institutions, and high net worth individuals, through public and private funds, listed partnerships, separate accounts, and co-investments. Founded in 2022 and headquartered in New York, the firm operates as a subsidiary of Brookfield Corporation and uses fundamental and operational analysis, supported by both in-house and external research, to guide its investment decisions.
As an asset manager, the firm typically generates revenue through management fees charged on assets under management, along with performance-based fees tied to investment returns, which is the standard economic model across the asset management industry. Brookfields emphasis on real assets distinguishes it within the broader Financials sector, as these long-duration, often inflation-linked categories (such as infrastructure and renewable power) appeal to institutional investors seeking stable, long-term cash flows.
- Fee-bearing capital growth accelerates fee-related earnings
- Real assets and infrastructure fundraising boost AUM
- Private credit and insurance partnerships expand revenue streams
| Net Income: 2.79b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 7.68 > 1.0 |
| NWC/Revenue: 18.30% < 20% (prev 48.43%; Δ -30.12% < -1%) |
| CFO/TA 0.11 > 3% & CFO 2.18b > Net Income 2.79b |
| Net Debt (12.0b) to EBITDA (3.73b): 3.21 < 3 |
| Current Ratio: 1.24 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.62b) vs 12m ago 5.37% < -2% |
| Gross Margin: 80.17% > 18% (prev 70.93%; Δ 9.25% > 0.5%) |
| Asset Turnover: 29.84% > 50% (prev 26.95%; Δ 2.88% > 0%) |
| Interest Coverage Ratio: 13.67 > 6 (EBIT TTM 3.68b / Interest Expense TTM 269.3m) |
| A: 0.05 (Total Current Assets 5.04b - Total Current Liabilities 4.05b) / Total Assets 20.1b |
| B: -0.05 (Retained Earnings -950.0m / Total Assets 20.1b) |
| C: 0.20 (EBIT TTM 3.68b / Avg Total Assets 18.1b) |
| D: 0.91 (Book Value of Equity 7.51b / Total Liabilities 8.21b) |
| Altman-Z'' = 2.50 = A |
| DSRI: 0.52 (Receivables 3.54b/5.48b, Revenue 5.40b/4.35b) |
| GMI: 0.88 (GM 70.93% / 80.17%) |
| AQI: 1.19 (AQ_t 0.74 / AQ_t-1 0.63) |
| SGI: 1.24 (Revenue 5.40b / 4.35b) |
| TATA: 0.03 (NI 2.79b - CFO 2.18b) / TA 20.1b) |
| Beneish M = -3.24 (Cap -4..+1) = AA |
As of October 31, 2026, the stock is trading at USD 48.26 with a total of 2,110,543 shares traded. Over the past week, the price has changed by +2.62%, over one month by +7.32%, over three months by +1.60% and over the past year by -6.52%.
Current recommended Stop Loss: 45.80 (which is 5.1% or 2.1 ATR below the current price).
Brookfield Asset Management has received a consensus analysts rating of 3.79. Therefore, it is recommended to hold BAM.
- StrongBuy: 7
- Buy: 3
- Hold: 8
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 55.8 | 15.6% |
P/E Trailing = 27.0345
P/E Forward = 21.5517
P/S = 13.0965
P/B = 9.9985
P/EG = 0.8165
Revenue TTM = 5.40b USD
EBIT TTM = 3.68b USD
EBITDA TTM = 3.73b USD
Long Term Debt = 4.67b USD (from longTermDebt, last quarter)
Short Term Debt = 589.0m USD (from shortTermDebt, last quarter)
Debt = 13.5b USD (corrected: LT Debt 4.67b + ST Debt 589.0m) + Leases 8.22b
Net Debt = 12.0b USD (calculated: Debt 13.5b - CCE 1.50b)
Enterprise Value = 87.1b USD (75.1b + Debt 13.5b - CCE 1.50b)
Interest Coverage Ratio = 13.67 (Ebit TTM 3.68b / Interest Expense TTM 269.3m)
EV/FCF = 39.98x (Enterprise Value 87.1b / FCF TTM 2.18b)
FCF Yield = 2.50% (FCF TTM 2.18b / Enterprise Value 87.1b)
FCF Margin = 40.32% (FCF TTM 2.18b / Revenue TTM 5.40b)
Net Margin = 51.60% (Net Income TTM 2.79b / Revenue TTM 5.40b)
Gross Margin = 80.17% ((Revenue TTM 5.40b - Cost of Revenue TTM 1.07b) / Revenue TTM)
Gross Margin QoQ = 92.53% (prev 82.29%)
Tobins Q-Ratio = 4.34 (Enterprise Value 87.1b / Total Assets 20.1b)
Interest Expense / Debt = 2.00% (Interest Expense 269.3m / Debt 13.5b)
Taxrate = 17.48% (647.5m / 3.70b)
NOPAT = 3.04b (EBIT 3.68b * (1 - 17.48%))
Current Ratio = 1.24 (Total Current Assets 5.04b / Total Current Liabilities 4.05b)
Debt / Equity = 1.79 (Debt 13.5b / totalStockholderEquity, last quarter 7.51b)
Debt / EBITDA = 3.21 (Net Debt 12.0b / EBITDA 3.73b)
Debt / FCF = 5.50 (Net Debt 12.0b / FCF TTM 2.18b)
Total Stockholder Equity = 7.92b (last 4 quarters mean from totalStockholderEquity)
RoA = 15.40% (Net Income 2.79b / Total Assets 20.1b)
RoE = 35.20% (Net Income TTM 2.79b / Total Stockholder Equity 7.92b)
RoCE = 29.24% (EBIT 3.68b / Capital Employed (Equity 7.92b + L.T.Debt 4.67b))
RoIC = 18.59% (NOPAT 3.04b / Invested Capital 16.3b)
WACC = 9.15% (E(75.1b)/V(88.6b) * Re(10.50%) + D(13.5b)/V(88.6b) * Rd(2.00%) * (1-Tc(0.17)))
Discount Rate = 10.50% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 22.34 | Cagr: 0.76%
[DCF] Terminal Value 75.41% ; FCFF base≈1.51b ; Y1≈1.73b ; Y5≈2.55b
[DCF] Fair Price = 13.56 (EV 33.6b - Net Debt 12.0b = Equity 21.7b / Shares 1.60b; r=9.15% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 98.32 | EPS CAGR: 10.19% | SUE: 0.49 | # QB: 0
Revenue Correlation: 85.05 | Revenue CAGR: 9.79% | SUE: 0.83 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.47 | Chg30d=+0.84% | Revisions=+0% | Analysts=15
EPS current Year (2026-12-31): EPS=1.83 | Chg30d=-0.10% | Revisions=-38% | GrowthEPS=+11.0% | GrowthRev=+28.2%
EPS next Year (2027-12-31): EPS=2.15 | Chg30d=-0.97% | Revisions=-50% | GrowthEPS=+17.4% | GrowthRev=+15.7%
[Analyst] Revisions Ratio: -46% (up=2, down=8)